At an event at Tyndall recently, more than 90 delegates from across Europe travelled to Cork for the closing event of the Moore4Medical project. The project worked on exciting developments in medical technology.
The Moore4Medical EC ECSEL project, comprising of 68 partners from across Europe, is focused on advancing open technology platforms to accelerate innovation in emerging medical devices.
Significant opportunities
The research addresses emerging medical applications and technologies that offer significant opportunities for patients as well as for industry including:
- Bioelectronic medicines;
- Organ-on-chip;
- Drug adherence monitoring;
- Smart ultrasound;
- Radiation free interventions;
- Continuous monitoring.
The new technologies will help fight the increasing cost of healthcare by: reducing the need for hospitalisation, helping to develop personalised therapies, and realising intelligent point-of-care diagnostic tools.
The final project meeting involving more than 90+ delegates, which was co-hosted by the Irish partners including Tyndall, Abbvie, Boston Scientific and Integer, was held at Tyndall National Institute (Cork, Ireland) in early May.
Successful technology outputs were showcased, based on selected demonstrators, presentations and a poster session.
Moore4Medical is an exemplar multinational, multidisciplinary project, led by Philips, not only for advancing a range of emerging medical device technologies, but also for advancing beyond state-of-the-art knowledge and know-how for design, manufacture and testing of emerging digital health tech.
Tyndall is a proud partner of the Moore4Medical project, thanks to joint funding from EC ECSEL programme and Enterprise Ireland, and we were delighted to welcome the consortium to Tyndall and Cork.